|
|
Article: Research from Royal Adelaide Hospital, Department of Cardiology provides new data on heart failure therapy.
- Article from:
- Heart Disease Weekly
- Article date:
- November 15, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
A report, 'Evidence-based management of heart failure in clinical practice: a review of device-based therapy use,' is newly published data in Internal Medicine Journal. "Heart failure is a growing health issue and is associated with significant mortality risk. Device therapy is efficacious in preventing sudden death in patients with heart failure; however, this evidence comes from rigorous clinical trials," scientists in Adelaide, Australia report (see also Heart Failure Therapy).
"It is unclear how device therapy is utilized in 'real-world' practice. The primary objective was to characterize patterns of device use in patients with heart failure at risk of ...
<0.001), more likely to have ischaemic cardiomyopathy (p=0.002), less likely to be prescribed spironolactone (p=0.005) or warfarin (p=0.02), and less likely to have a widened QRS>
Related newspaper, magazine, and journal articles:
|
|
Article: University of Regensburg, Department of Internal ...
Heart Disease Weekly;
March 22, 2009 ;
700+ words
... ... Keywords: Germany, Regensburg, Heart Failure Prevention, Cardiology, Chronic Heart Failure, Congestive Heart Failure, Coronary Artery Disease, Heart Attack, Heart Disease, Internal Medicine, Sleep Research, Therapy, Treatment ...
|
|